Adimab, Inc. Announces Series C Financing

LEBANON, N.H.--(BUSINESS WIRE)--Adimab, Inc., a leading antibody discovery company, today announced the closing of a Series C financing. The total amount of the financing was not disclosed.
MORE ON THIS TOPIC